UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of Earliest Event Reported): December 30, 2013
PHYSICIANS REALTY TRUST
(Exact name of registrant as specified in its charter)
|
Maryland |
|
001-36007 |
|
46-2519850 |
|
(State or other jurisdiction |
|
(Commission |
|
(I.R.S. Employer |
|
of incorporation) |
|
File Number) |
|
Identification No.) |
|
250 East Wisconsin Avenue, Suite 1900 |
|
|
|
Milwaukee, Wisconsin |
|
53202 |
|
(Address of principal executive offices) |
|
(Zip Code) |
Registrant’s telephone number, including area code: (414) 978-6494
Not Applicable
Former name or former address, if changed since last report
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under o the Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under o the Exchange Act (17 CFR 240.13e-4(c))
Item 8.01. Other Events.
On December 30, 2013, the Company issued a press release announcing that the Board of Trustees declared a quarterly cash dividend of $0.225 per common share of beneficial interest for the quarter ending December 31, 2013. The dividend will be payable on February 7, 2014 to common shareholders of record on January 24, 2014.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibit 99.1 is attached to this 8-K
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
|
PHYSICIANS REALTY TRUST | ||
|
|
|
| |
|
December 30, 2013 |
By: |
/s/ John T. Thomas | |
|
|
|
Name: |
John T. Thomas |
|
|
|
Title: |
President and Chief Executive Officer |